Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

VBLT

Vascular Biogenics (VBLT)

Vascular Biogenics Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VBLT
FechaHoraFuenteTítuloSímboloCompañía
10/05/202416:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
06/05/202415:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
19/04/202415:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VBLTVascular Biogenics Ltd
11/04/202416:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VBLTVascular Biogenics Ltd
01/04/202415:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:VBLTVascular Biogenics Ltd
16/02/202408:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
05/02/202416:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
11/01/202416:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
08/01/202415:21Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:VBLTVascular Biogenics Ltd
29/11/202316:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
26/10/202316:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/10/202316:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VBLTVascular Biogenics Ltd
19/10/202312:34Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:VBLTVascular Biogenics Ltd
17/10/202316:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/10/202307:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:VBLTVascular Biogenics Ltd
02/10/202316:29Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VBLTVascular Biogenics Ltd
05/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VBLTVascular Biogenics Ltd
05/09/202314:52Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
14/08/202307:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBLTVascular Biogenics Ltd
09/06/202315:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202315:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202315:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VBLTVascular Biogenics Ltd
18/04/202315:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VBLTVascular Biogenics Ltd
14/03/202307:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VBLTVascular Biogenics Ltd
09/12/202216:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:VBLTVascular Biogenics Ltd
18/11/202205:15TipRanksH.C. Wainwright Reaffirms Their Hold Rating on Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
20/07/202207:55TipRanksVascular Biogenics (VBLT) Receives a Hold from JonesTradingNASDAQ:VBLTVascular Biogenics Ltd
20/07/202205:15TipRanksAnalysts Offer Insights on Healthcare Companies: Celsion (CLSN), Vascular Biogenics (VBLT) and Portage Biotech Inc (PRTG)NASDAQ:VBLTVascular Biogenics Ltd
20/05/202212:25TipRanksJonesTrading Remains a Buy on Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
18/05/202205:17TipRanksH.C. Wainwright Sticks to Their Buy Rating for Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
 Showing the most relevant articles for your search:NASDAQ:VBLT

Su Consulta Reciente

Delayed Upgrade Clock